Table 4. Characteristics of Study and Historical Control Subjects.
Study | CIBMTR | |
---|---|---|
N=62 | N=347 | |
Age, median | 39 y | 36 y |
> 40 y * | 48% | 34% |
Caucasian * | 85% | 68% |
HLA-identical sib donor * | 48% | 68% |
Sex-match: F to M* | 51% | 23% |
D/R CMV | ||
−/− | 22% | 35% |
−/+ | 18% | 18% |
+/− | 13% | 10% |
+/+ | 47% | 37% |
Peripheral blood graft | 52% | 39% |
Disease * | ||
Acute leukemia | 53% | 49% |
Chronic leukemia | 29% | 33% |
MDS | 5% | 7% |
NHL | 8% | 12% |
Other | 5% | <1% |
Advanced Disease | 48% | 44% |
p < 0.05
Sex match: F to M indicates female to male; D/R CMV, donor recipient cytomegalovirus status; advanced disease defined as beyond first complete remission or never obtaining remission.